Large-scale testing (Phase 3)Study completedNCT00167154What this trial is testingRisperidone and Suicidality in Major Depressive DisorderWho this might be right forDepression University of Alabama at Birmingham 30
Large-scale testing (Phase 3)UnknownNCT03284294What this trial is testingInfluence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in SchizophreniaWho this might be right forSchizophrenia Universitas Padjadjaran 40
Not applicableStudy completedNCT00999895What this trial is testingA Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic PatientsWho this might be right forSchizophrenia AstraZeneca 574
Post-approval studies (Phase 4)UnknownNCT02040883What this trial is testingTandospirone Combined With Atypical Antipsychotic Drugs in SchizophreniaWho this might be right forSchizophrenia Qingyun Yin 100
Testing effectiveness (Phase 2)Ended earlyNCT04421456What this trial is testingTrial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic TreatmentWho this might be right forSchizophrenia Jazz Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT00253136What this trial is testingThe Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaWho this might be right forSchizophreniaPsychotic Disorders Janssen, LP 458
Post-approval studies (Phase 4)Study completedNCT00014001What this trial is testingCATIE- Schizophrenia TrialWho this might be right forSchizophrenia National Institute of Mental Health (NIMH) 1,600
Early research (Phase 1)Study completedNCT02184767What this trial is testingStudy to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationWho this might be right forBiPolar Teva Branded Pharmaceutical Products R&D, Inc. 30
Not applicableUnknownNCT04784572What this trial is testingAssessment of Pain During Intramuscular Injection Delay in Adult PsychiatryWho this might be right forDelayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors Centre hospitalier de Ville-Evrard, France 393
Post-approval studies (Phase 4)UnknownNCT00182494What this trial is testingDiabetes Prevention Program in Schizophrenia [DPPS]Who this might be right forDiabetes MellitusSchizophrenia Hamilton Health Sciences Corporation 200
Not applicableUnknownNCT06238089What this trial is testingAnti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and WalesWho this might be right forIntellectual Disability University of Plymouth 600
Not applicableStudy completedNCT00903916What this trial is testingEffect of Antipsychotics on Appetite RegulationWho this might be right forPsychotic Disorders University of North Carolina, Chapel Hill 45
Post-approval studies (Phase 4)Study completedNCT00202293What this trial is testingComparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesWho this might be right forBipolar DisorderSchizoaffective Disorder Melbourne Health 83
Early research (Phase 1)Study completedNCT02634463What this trial is testingWhole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneWho this might be right forImmunoassayAntipsychotic Janssen Research & Development, LLC 81
Early research (Phase 1)Study completedNCT05542264What this trial is testingA Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With SchizophreniaWho this might be right forSchizophrenia Otsuka Pharmaceutical Development & Commercialization, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT00279409What this trial is testingTreatment of Children With ADHD Who do Not Fully Respond to StimulantsWho this might be right forAttention Deficit Hyperactivity Disorder New York State Psychiatric Institute 10
Post-approval studies (Phase 4)Study completedNCT00330551What this trial is testingOral Versus Injectable Risperidone for Treating First-Episode SchizophreniaWho this might be right forSchizophrenia University of California, Los Angeles 126
Not applicableStudy completedNCT01029769What this trial is testingEfficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of SchizophreniaWho this might be right forSchizophreniaSchizoaffective DisorderSchizophreniform Disorder Technical University of Munich 350
Large-scale testing (Phase 3)Study completedNCT00215254What this trial is testingQuetiapine in Social Anxiety DisorderWho this might be right forSocial Anxiety Disorder Duke University 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770282What this trial is testingEfficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic SyndromeWho this might be right forSchizophrenia DisorderMetabolic SyndromeAntipsychotic-induced Weight Gain+2 more All India Institute of Medical Sciences, Bhubaneswar 600